Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saverio Minucci

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cellsFrancesca Cianci, Ivan Verduci, Riccardo Cazzoli, et al.
Journal of Medicinal Chemistry|February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary ExplorationLuca Sartori, Ciro Mercurio, Federica Amigoni, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cellsFrancesca Cianci, Ivan Verduci, Riccardo Cazzoli, et al.
Molecular Cancer Therapeutics|October 5, 2013
Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificitiesAndrea Newbold, Geoffrey M Matthews, Michael Bots, et al.
Archiv Der Pharmazie|May 10, 2025
Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AMLNada Alaa El-Deen, RosaAnna DeFilippis, Amal Kamal Abdel-Aziz, et al.
Nature Communications|December 1, 2025
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesisWentao Gui, Petr Paral, Bhavuk Dhamija, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune EvasionFabio Conforti, Laura Pala, Eleonora Pagan, et al.
International Journal of Cancer|March 9, 2019
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancerMohamed Elgendy, Juan Pablo Fusco, Victor Segura, et al.
Science Signaling|December 19, 2023
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronavirusesLuca Mazzarella, Fabio Santoro, Roberto Ravasio, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cellsFrancesca Cianci, Ivan Verduci, Riccardo Cazzoli, et al.
Journal of Medicinal Chemistry|February 11, 2017
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary ExplorationLuca Sartori, Ciro Mercurio, Federica Amigoni, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cellsFrancesca Cianci, Ivan Verduci, Riccardo Cazzoli, et al.
Molecular Cancer Therapeutics|October 5, 2013
Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificitiesAndrea Newbold, Geoffrey M Matthews, Michael Bots, et al.
Archiv Der Pharmazie|May 10, 2025
Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AMLNada Alaa El-Deen, RosaAnna DeFilippis, Amal Kamal Abdel-Aziz, et al.
Nature Communications|December 1, 2025
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesisWentao Gui, Petr Paral, Bhavuk Dhamija, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune EvasionFabio Conforti, Laura Pala, Eleonora Pagan, et al.
International Journal of Cancer|March 9, 2019
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancerMohamed Elgendy, Juan Pablo Fusco, Victor Segura, et al.
Science Signaling|December 19, 2023
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronavirusesLuca Mazzarella, Fabio Santoro, Roberto Ravasio, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Pageof 17